SOX9 and gastric cancer: Similarly, low SOX9 mutation rates were observed in Asian GC patients including TCGA GC (Asian) samples (2.2%, 2/89) and GC cohorts from Hong Kong17 (2%, 2/100) and Singapore24 (3.3%, 7/213) (Table S3).